Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints

Plasmacytoid Dendritic Cells: Development, Regulation, and Function

(2019) Boris Reizis   IMMUNITY

A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation

(2019) Yunyun Yang et al.   IMMUNITY

γδ T Cell Update: Adaptate Orchestrators of Immune Surveillance

(2019) Adrian C. Hayday   JOURNAL OF IMMUNOLOGY

Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology

(2018) Pierre Vantourout et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters

(2018) David A. Rhodes et al.   Frontiers in Immunology

Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells

(2018) Lola Boutin et al.   Frontiers in Immunology

New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity

(2018) Juan-Luis Blazquez et al.   Frontiers in Immunology

The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells

(2017) Barbara Castella et al.   Nature Communications

γδ T Cell-Mediated Immunity to Cytomegalovirus Infection

(2017) Camille Khairallah et al.   Frontiers in Immunology

Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications

(2017) Myriam Lawand et al.   Frontiers in Immunology

Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity

(2017) Maria Raffaella Zocchi et al.   OncoImmunology

Survival of patients with advanced metastatic melanoma: The impact of novel therapies

(2016) Selma Ugurel et al.   EUROPEAN JOURNAL OF CANCER

Memory γδ T Cells–Newly Appreciated Protagonists in Infection and Immunity

(2016) Stephen J. Lalor et al.   TRENDS IN IMMUNOLOGY

Activation and selective IL-17 response of human Vγ9Vδ2 T lymphocytes by TLR-activated plasmacytoid dendritic cells

(2016) Elena Lo Presti et al.   Oncotarget

Activation of Human γδ T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin

(2015) David A. Rhodes et al.   JOURNAL OF IMMUNOLOGY

Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells

(2015) Siyi Gu et al.   Frontiers in Immunology

Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells

(2015) Christelle Harly et al.   Frontiers in Immunology

Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy

(2015) Heleen H Van Acker et al.   OncoImmunology

The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells

(2014) Andrew Sandstrom et al.   IMMUNITY

HIV Infection of Monocytes-Derived Dendritic Cells Inhibits Vγ9Vδ2 T Cells Functions

(2014) Alessandra Sacchi et al.   PLoS One

The Vγ9Vδ2 T Cell Antigen Receptor and Butyrophilin-3 A1: Models of Interaction, the Possibility of Co-Evolution, and the Case of Dendritic Epidermal T Cells

(2014) Mohindar M. Karunakaran et al.   Frontiers in Immunology

Plasticity of γδ T Cells: Impact on the Anti-Tumor Response

(2014) Virginie Lafont et al.   Frontiers in Immunology

Melanoma hijacks plasmacytoid dendritic cells to promote its own progression

(2014) Caroline Aspord et al.   OncoImmunology

Harnessing the immune system to provide long-term survival in patients with melanoma and other solid tumors

(2014) Alexander Eggermont et al.   OncoImmunology

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

(2013) J. Tel et al.   CANCER RESEARCH

Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells

(2013) Stefano Vavassori et al.   NATURE IMMUNOLOGY

Zoledronate-pulsed dendritic cell-based anticancer vaccines

(2013) Takashi Kamigaki et al.   OncoImmunology

Harnessing human plasmacytoid dendritic cells as professional APCs

(2012) Jurjen Tel et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Impaired IFN-  Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression

(2012) V. Sisirak et al.   CANCER RESEARCH

HLA-A*0201 + Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients

(2012) Caroline Aspord et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Harnessing γδ T cells in anticancer immunotherapy

(2012) Dalil Hannani et al.   TRENDS IN IMMUNOLOGY

Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses

(2010) Roberto Lande et al.   Annals of the New York Academy of Sciences

Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients

(2010) Florian Cabillic et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

(E)-4-Hydroxy-3-methyl-but-2 enyl pyrophosphate-stimulated Vγ9Vδ2 T cells possess T helper type 1-promoting adjuvant activity for human monocyte-derived dendritic cells

(2010) Margaret R. Dunne et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

γδd T cells promote the maturation of dendritic cells during West Nile virus infection

(2010) Hao Fang et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

CD2 Distinguishes Two Subsets of Human Plasmacytoid Dendritic Cells with Distinct Phenotype and Functions

(2009) T. Matsui et al.   JOURNAL OF IMMUNOLOGY

Early Triggering of Exclusive IFN-  Responses of Human V 9V 2 T Cells by TLR-Activated Myeloid and Plasmacytoid Dendritic Cells

(2009) M.-C. Devilder et al.   JOURNAL OF IMMUNOLOGY

Bridging innate and adaptive immunity through gd T - dendritic cell crosstalk

(2008) Emmanuel Scotet   Frontiers in Bioscience-Landmark

Antigen-Presentation Properties of Plasmacytoid Dendritic Cells

(2008) José A. Villadangos et al.   IMMUNITY